HIV/AIDS Anti-Diarrheal Drug Fulyzaq (Crofelemer) Approved By FDA
The first anti-diarrheal drug for HIV/AIDS patients, Fulyzaq (crofelemer 125 mg delayed-release tablets), has been approved by the FDA (Food
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓